Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00764049

Single Pass Albumin Dialysis in Patients With Cirrhosis (DACAR)

Prospective Pilot Study Assessing Safety and Efficacy of Single Pass Albumin Dialysis in Patients With Acute on Chronic Liver Failure

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Acute on Chronic Hepatic Failure Cirrhosis Encephalopathy Hepatorenal Syndrome

Interventions Single pass albumin dialysis

Updated 5 times since 2017 Last updated: Feb 24, 2015 Started: Jun 30, 2009 Primary completion: Jan 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Acute on Chronic Hepatic Failure and Cirrhosis and is currently completed. Assistance Publique - Hôpitaux de Paris leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France
Laboratoire français de Fractionnement et de Biotechnologies

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clichy, France